Development of Integrated Stress Response Inhibitor RTX-117 as a Treatment for Neurodegenerative Diseases (P9-11.028)

Authors

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211947
Primary Topic
Cholinesterase and Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of Integrated Stress Response Inhibitor RTX-117 as a Treatment for Neurodegenerative Diseases (P9-11.028)

Mary McMahon, Steve Lianoglou, Paul R. August, Liu Yang et al.
Neurology
Cholinesterase and Neurodegenerative Diseases
article

Development of Integrated Stress Response Inhibitor RTX-117 as a Treatment for Neurodegenerative Diseases (P9-11.028)

Mary McMahon, Steve Lianoglou, Paul R. August, Liu Yang, Sowmya Narayan, Jinxing Li, Jeff Zhang, Jawad Abid
article en

Abstract

No abstract available for this paper.
NeurologyVol. 104(7_Supplement_1)
Openalex Percentile: Top 92%
Cholinesterase and Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of Integrated Stress Response Inhibitor RTX-117 as a Treatment for Neurodegenerative Diseases (P9-11.028) — Mary McMahon, Steve Lianoglou, et al. · Neurology (2025) | TGRS Research Map | TGRS